Compare IDEXX Laboratories, Inc. (IDXX) vs SoundHound AI Inc (SOUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs SoundHound AI Inc — how do they compare? IDEXX Laboratories, Inc. trades at $571 (market cap $46.22B), while SoundHound AI Inc trades at $7.4 (market cap $3.29B). The key difference: IDEXX Laboratories, Inc. is far larger — about 14× SoundHound AI Inc's market cap. Which is the better fit depends on your goals.
| IDXX | SOUN | |
|---|---|---|
Market Cap | $46.22B | $3.29B |
Sector | Health | Technology |
52-Week High | $766.68 | $21.40 |
52-Week Low | $526.44 | $5.70 |
Enterprise Value | $47.12B | $3.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
SoundHound AI (SOUN) trades at $7.40, down 0.8% on the day, with strong technical momentum indicated by bullish moving averages. The company shows impressive revenue growth of 45% in Q2 2026 and has beaten earnings expectations for three consecutive quarters. Recent news highlights the proposed LivePerson acquisition and the successful launch of the OASYS platform, which is accelerating enterprise adoption and driving improved guidance.
While growth prospects appear promising with 75% analyst buy ratings and an $8.50 consensus target, significant risks remain including persistent negative margins (-67.45% net income margin), high valuation multiples (P/S 15.31), and substantial cash burn. The stock offers growth potential but requires careful risk management given the premium valuation and path to profitability challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →
